New On-Demand Education – Juvenile idiopathic arthritis (JIA) Trainings and Journal Club

Join the Ohio AAP for trainings and journal club to prepare providers in any setting to identify and address patients with juvenile arthritis! Juvenile idiopathic arthritis (JIA) impacts nearly 300,000 children in the US – with trends suggesting that the prevalence of this disorder is increasing. Due to a shortage of specialists, the primary care provider plays an important role in the management of pediatric JIA.

The Ohio AAP’s final webinar training is scheduled for next week. Additional details below!

  • February 23, 2022 – 12:00 – 1:00 pm– Learn about pain syndromes with our panel of experts.

The JIA journal club is a web-based educational program that provides pediatricians with opportunities to read and reflect on current journal articles on your own time, and highlights research and clinical topics that can positively impact the delivery of care to patients. Our latest on-demand, user-friendly educational opportunity provides more in-depth education on pediatric JIA, and includes 10 modules with topics ranging from Hypermobility to Infectious Arthritis, Depression & Anxiety, Transition to Adult Care, and much more!

Our new series provides a listing of selected articles and a post-test for each article. Participants are expected to read each article and complete the post-test successfully in order to receive 20 points of AMA PRA Category 1 creditTM  and American Board of Pediatrics MOC Part II points.

Individuals interested in participating in this web-based journal series, please enroll (using the link below), take the Pre-Test Survey, and begin participating in selected article(s) on an individual basis. Participation in each article will be managed as individual learning activities and credit awarded per article. Once all 10 modules are completed, participants will take the final Post-Test Survey.

For more information or if you have any questions, please contact Lory Sheeran Winland at lwinland@ohioaap.org.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published.